IPG Photonics Corporation
IPGPTechnologyNASDAQSemiconductor Equipment & Materials
Scan Results
Daily timeframeIPG Photonics Corporation develops, manufactures, and sells fiber lasers, fiber amplifiers, diode lasers, and laser-based systems used in materials processing, medical, and advanced applications. With a market capitalization of $3.38B, it sits in mid-cap territory. The company offers laser products, including hybrid fiber-solid state lasers with green and ultraviolet wavelengths; fiber pigtailed packaged diodes and fiber coupled direct diode laser systems; and high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization and single-frequency lasers, as well as other versions.
Market Cap
$3.38B
Beta
0.98
P/E (TTM)
122.40
P/E (Fwd)
34.81
EPS (TTM)
$0.65
EPS (Fwd)
$2.29
ROE
1.3%
ROA
1.0%
Cash
$871.3M
Total Debt
$16.3M
Free CF
$45.3M
52W Change
-4.4%
Annual Financials
Cash vs Debt
Where IPGP stands vs its 150-day and 200-day moving averages
As of the September 2, 2026 close, IPGP finished 31.00% below its 150-day moving average ($108.99) and 25.85% below its 200-day moving average ($101.41). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is IPGP overbought or oversold?
At the September 2, 2026 close, IPGP's RSI(14) was 31.9, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
IPG Photonics Corporation holds $871.3M in cash against $16.3M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $45.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 1.3% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.0% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $1.43B (2022) to $1.00B (2025), a 30% decline worth watching.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. At over 50x earnings, IPGP carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing IPGP.